Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

87 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Ferric carboxymaltose for the treatment of iron deficiency in heart failure: a multinational cost-effectiveness analysis utilising AFFIRM-AHF.
McEwan P, Ponikowski P, Davis JA, Rosano G, Coats AJS, Dorigotti F, O'Sullivan D, Ramirez de Arellano A, Jankowska EA. McEwan P, et al. Among authors: ramirez de arellano a. Eur J Heart Fail. 2021 Oct;23(10):1687-1697. doi: 10.1002/ejhf.2270. Epub 2021 Jun 30. Eur J Heart Fail. 2021. PMID: 34191394 Free PMC article.
Iron Formulations for the Treatment of Iron Deficiency Anemia in Patients with Inflammatory Bowel Disease: A Cost-Effectiveness Analysis in Switzerland.
Aksan A, Schoepfer A, Juillerat P, Vavricka S, Bettencourt M, Ramirez de Arellano A, Gavata S, Morin N, Valentine WJ, Hunt B. Aksan A, et al. Among authors: ramirez de arellano a. Adv Ther. 2021 Jan;38(1):660-677. doi: 10.1007/s12325-020-01553-1. Epub 2020 Nov 20. Adv Ther. 2021. PMID: 33216324 Free PMC article.
A Response to: Letter to the Editor Regarding 'Iron Formulations for the Treatment of Iron Deficiency Anemia in Patients with Inflammatory Bowel Disease: A Cost-Effectiveness Analysis in Switzerland'.
Aksan A, Schoepfer A, Juillerat P, Vavricka S, Bettencourt M, Ramirez de Arellano A, Gavata S, Morin N, Valentine WJ, Hunt B. Aksan A, et al. Among authors: ramirez de arellano a. Adv Ther. 2022 Jan;39(1):815-821. doi: 10.1007/s12325-021-02001-4. Epub 2021 Nov 30. Adv Ther. 2022. PMID: 34846708 Free PMC article. No abstract available.
A cost-effectiveness analysis of patiromer for the treatment of hyperkalemia in chronic kidney disease patients with and without heart failure in Spain.
González-Juanatey JR, González-Franco Á, de Sequera P, Valls M, Ramirez de Arellano A, Pomares E, Nieves D. González-Juanatey JR, et al. Among authors: de sequera p, ramirez de arellano a. J Med Econ. 2022 Jan-Dec;25(1):640-649. doi: 10.1080/13696998.2022.2074193. J Med Econ. 2022. PMID: 35510569 Free article.
Cost-effectiveness analysis of insulin degludec compared with insulin glargine u100 for the management of type 1 and type 2 diabetes mellitus - from the Spanish National Health System perspective.
Mezquita-Raya P, Darbà J, Ascanio M, Ramírez de Arellano A. Mezquita-Raya P, et al. Among authors: ramirez de arellano a. Expert Rev Pharmacoecon Outcomes Res. 2017 Dec;17(6):587-595. doi: 10.1080/14737167.2017.1345628. Epub 2017 Jul 3. Expert Rev Pharmacoecon Outcomes Res. 2017. PMID: 28649881 Free article.
87 results